44 results on '"James, Paula D"'
Search Results
2. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States
3. The Empower Study - Design of a Randomized Clinical Trial to Assess the Efficacy and Safety of a Plasma-Derived Von Willebrand Factor / Factor VIII Concentrate for Heavy Menstrual Bleeding in Women with Von Willebrand Disease
4. Take Control. Period. -Interactive Patient Education Website Enhances Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding
5. Investigating the Role of Von Willebrand Factor (VWF) in Modulating In Vivo angiogenesis in VWF-Deficient Mice
6. Alloantibodies in von Willebrand disease
7. The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels
8. A Major Knowledge Gap in Women's Health: The Combined Effect of Antifibrinolytics and Estrogen on Risk of Thromboembolism - a Scoping Review
9. Aminoglycoside suppression of nonsense mutations in severe hemophilia
10. A novel type 2A von Willebrand factor mutation located at the last nucleotide of exon 26 (3538G>A) causes skipping of 2 nonadjacent exons
11. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease
12. Take Control. Period. - Needs Assessment Leading to the Development of a Digital Quality Improvement Intervention Designed to Enhance Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding
13. Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program
14. Reducing Unnecessary Coagulation Testing in Outpatients (REDUCTION): A Quality Improvement Project
15. Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts
16. Interim Canadian Data from a Prospective, Observational Study of Routine Clinical Use of a Von Willebrand Factor Concentrate (Wilate®)
17. Novel Insights into the Clinical Phenotype and Pathophysiology Underlying Low VWF Levels: The Low Von Willebrand Factor in Ireland Cohort (LoVIC) Study
18. Let's Talk Period: Preliminary Results of an Online Bleeding Awareness Knowledge Translation Project and Bleeding Assessment Tool Promoted on Social Media
19. Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls
20. Testing for Heparin Induced Thrombocytopenia: Comparison of Practice at an Academic Center with Choosing Wisely Guidelines
21. Use of Bleeding Assessment Tools in the Diagnosis of Von Willebrand Disease: Are We Asking the Right Questions?
22. Validation of the Modified Self-Administered Pediatric Bleeding Assessment Questionnaire (Self-PBQ) in Children Aged 8-12 Years
23. Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD
24. No BS! Bleeding scores predict future bleeding
25. Investigating the Role of Von Willebrand Factor (VWF) in Modulating In Vivoangiogenesis in VWF-Deficient Mice
26. Regulation Of Factor VIII Clearance By Mannose-Binding Lectins
27. The Endothelial Lectin Receptor CLEC4M Internalizes Factor VIII and Von Willebrand Factor Via a Clathrin-Coated Pit-Dependent Mechanism
28. Normal Range Of Bleeding Scores For The ISTH-BAT: Adult and Pediatric Data From The Merging Project
29. Characterization Of Von Willebrand Factor Splice Variants From Exonic & Intronic Splicing Mutations
30. Heterogeneity Of Type 3 Von Willebrand Disease (VWD): Evidence From Patient-Derived Blood Outgrowth Endothelial Cells (BOEC)
31. In Vitro and Ex Vivo Investigation of Aberrant and Alternative Splicing of Von Willebrand Factor.
32. Genetic Variability of the CLEC4M Endothelial Lectin Receptor Modulates Binding and Internalization of Von Willebrand Factor and Contributes to Variance in Plasma VWF Levels
33. Prospective Comparison of the Pediatric Bleeding Questionnaire (PBQ) and the International Society On Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH-BAT) in Children Referred to a Tertiary-Care Pediatric Centre.
34. Rates of Malposition and Expulsion of the Levonorgestrel-Releasing Intrauterine System Among Women with Inherited Bleeding Disorders
35. Comparative Cellular Studies of the VWF Exon 4–5 Deletion Mutation Using Patient-Derived Blood Outgrowth Endothelial Cells (BOEC) and Megakaryocytes
36. Association of Quantitative and Qualitative Abnormalities of Von Willebrand Factor and Risk of Death In Hemodialysis Patients
37. Evaluation of the Severity and Pattern of Epistaxis In Children with a Mucocutaneous Bleeding Disorder and In Healthy Children Using a Standardized Questionnaire
38. Investigation of the Role of Copy Number Variation In the Pathogenesis of Type 1 Von Willebrand Disease
39. Type 3 Von Willebrand Disease: Plasma Versus Platelets.
40. Evaluation of Bleeding Symptoms in Children with An Inherited Mucocutaneous Bleeding Disorder.
41. The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study
42. VWD diagnosis: improved
43. Does Age Affect Desmopressin Responsiveness in Patients with Von Willebrand Disease?
44. In Vitroand Ex VivoInvestigation of Aberrant and Alternative Splicing of Von Willebrand Factor.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.